Cancer Monoclonal Antibodies Market 2015 Key Insights and 2020 Foreca Oct.2016 | Page 2
Global Cancer Monoclonal Antibodies Market
According to the report "Cancer Monoclonal Antibodies Market", published by Market Data
Forecast, the global market is projected to reach USD 45 Billion by 2020, at a CAGR of 11.2%
from 2015 to 2020.
For full report refer to http://www.marketdataforecast.com/market-reports/globalcancer-monoclonal-antibodies-market-185/
Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical
immune cells that are clones of a single parent cells and are directed to a specific cellular
targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and
can play a crucial role in eliminating the cancerous cell while sparing the normal cells during
the cancer treatment. The monoclonal antibodies are proved to be more effective than
chemotherapies and drugs for cancer treatment due to its specificity.
Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-cancer-monoclonal-antibodies-market-185/request-sample
The dramatic increase in the cancer cases has led many pharmaceutical companies to invest
in monoclonal antibodies market. Increasing investment in research and development of
genomic studies, technological advancements in genetic sequencing and target gene
selection, specificity of monoclonal antibodies to target only the cancer cells with no side
effects are the driving forces of the market. With the increased prevalence of cancer, it is
expected to grow lucratively in the next 5 years with the presence of strong products in the
pipeline.
Global Monoclonal Antibodies Market is segmented on the basis of application, type and
Conjugated Cancer therapies.
1.By Application
Liver
Breast
Brain
Blood
Hodgkins and Non-Hodgkins lymphoma
Colorectal
Leukaemia
And others
2.By Type
Murine Antibodies
Chimeric and Humanised Antibodies
Fully Humanized Antibodies
3.Conjugated Cancer Therapies
Immunoliposome
+1 888-702-9626 | www.marketdataforecast.com | [email protected]